MARIA STUMO: Open Payments
NPI 1326065350 · NEENAH, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 32 payments from 13 companies in 2025. Trend: 2023 $524 · 2024 $752 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $240 |
| Alnylam Pharmaceuticals Inc. | 3 | $81 |
| Amgen Inc. | 3 | $49 |
| Abbott Laboratories | 3 | $44 |
| PFIZER INC. | 2 | $40 |
| GENZYME CORPORATION | 2 | $39 |
| United Therapeutics Corporation | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| BridgeBio Pharma, Inc. | 1 | $21 |
Products named: LEQVIO, ONPATTRO, REPATHA, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, VYNDAQEL, FABRAZYME, Tyvaso, FARXIGA.
Industry payments across WI — which companies pay providers there.
